Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Alpha-methyldopa in schizophrenia

P Taylor, P K Gillman, R Gaind

The Journal of Clinical Psychiatry

|November 1, 1978

Summary

This summary is machine-generated.

An alpha-methyldopa overdose temporarily resolved schizophrenia symptoms by interfering with dopamine pathways. Psychosis returned weeks later, highlighting the complexity of dopamine

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SUBSTANCES RELATED TO 5-HYDROXYTRYPTAMINE IN PLASMA AND IN LUMBAR AND VENTRICULAR FLUIDS OF PSYCHIATRIC PATIENTS.

Acta psychiatrica Scandinavica·2017

Same author

Fatal methylene blue associated serotonin toxicity.

The Netherlands journal of medicine·2014

Same author

Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity.

Anaesthesia·2009

Same author

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.

Journal of psychopharmacology (Oxford, England)·2009

Same author

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.

British journal of pharmacology·2007

Same author

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.

British journal of pharmacology·2007

Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026

Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026

Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026

Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026

Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026

Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026

See all related articles

Area of Science:

Neuroscience
Psychiatry
Pharmacology

Background:

The dopamine hypothesis of schizophrenia posits excessive dopaminergic activity.
Alpha-methyldopa is known to inhibit central nervous system dopaminergic transmission.

Observation:

A case study involving a patient with schizophrenia who experienced an alpha-methyldopa overdose.
The overdose led to a striking, temporary remission of psychotic symptoms.

Findings:

The patient's psychotic symptoms resolved completely following the alpha-methyldopa overdose.
Psychosis recurred suddenly a few weeks after the overdose event.

Implications:

This case provides a unique, albeit temporary, clinical illustration of the dopamine hypothesis in schizophrenia.

Related Experiment Videos

It underscores the critical role of dopaminergic pathways in maintaining psychotic symptomology.

Further research into dopamine modulation for schizophrenia treatment may be warranted.